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The initial interaction between HIV and its host is cru-
cial in determining disease progression and uniquely
provides the ability to explore the determinants of HIV
acquisition. Upon this first encounter, the virus will
induce an innate and adaptive immune response that
will determine the severity of symptoms and the level of
T cell activation. To rationally design the optimal treat-
ment strategy, whether it immunotherapies or ART, this
brief time period is of the utmost importance. The chal-
lenge here lies in the conflict between the drive for
scientific knowledge and supporting the patient though
this emotional stage. However, only a delicate balance
between these necessities will produce successful trans-
lational research. In addition, integrating virological,
immunological and behavioural factors has become the
sole valid approach of properly addressing both HIV
pathogenesis and patient needs.
After two decades of HIV research, mucosa immunity
has emerged as a cornerstone of future research. Several
studies in both SIV and HIV infection have emphasized
the importance of depletion of mucosal CD4 T cells and
high levels of T cell activation immediately following
infection. The contribution of mucosal immunity has
shed light on the importance a4b7 mucosal homing
receptors, massive loss of memory CD4 T cells, micro-
bial translocation, and T cell activation. Recently, den-
dritic cells, monocytes, NK cells as well as the
interleukin-7 and interleukin-21 signalling pathways
have been shown to contribute to the early immune
dysfunction observed after infection. The timing of ART
initiation plays a major role on the quality of immune
recovery. In addition, the establishment of viral reservoir
occurs within days after infection and its size is largely
determined by the CD4 memory/effector ratio and CD4
cell nadir.
New frontiers in acute HIV infection research need to
include blood sampling by leukapheresis to collect large
quantities of immune cells, mucosa biopsies, and
neurocognitive evaluation to pave the route toward HIV
eradication and rational design of vaccines and
immunotherapies.
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